Full name
MOLTENI FARMACEUTICI POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
MOLTENI FARMACEUTICI POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JÓZEFA KORZENIOWSKIEGO 39, 30-214 KRAKÓW
TAX ID5210421696
Rate company:
MOLTENI FARMACEUTICI POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5210421696
KRS0000183641
Share capital1,364,000.00 zł
address
UL. JÓZEFA KORZENIOWSKIEGO 39, 30-214 KRAKÓW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5210421696
REGON
010650109
KRS
0000183641
Legal form
limited liability company
Register Address
UL. JÓZEFA KORZENIOWSKIEGO 39, 30-214 KRAKÓW
Date of registration in KRS
2004-01-30
Date of commencement of economic activity
2004-01-30
Act signature
KR.XI NS-REJ.KRS/23425/21/283/ADE
Pkd codes
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.1 - Scientific research and development in natural and technical sciences
73.1 - Advertising
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
Payer VAT status
Active
Vat list bank account(s)
PL27 1500 1142 1211 4000 6375 0000 
PL03 1500 1142 1211 4007 9076 0000 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,6 | 0,6 | 0,6 | 3,7 |
Gross profit (loss) | 0,6 | 0,6 | 0,9 | 41,8 |
EBITDA | 0,7 | 0,7 | 0,9 | 37,9 |
Short time liabilities | 0,2 | 0,3 | 0,3 | 19,7 |
Other operating costs | 0 | 0 | 0 | -64 |
Equity capital | 2,9 | 3,4 | 4 | 18,4 |
Operating profit (EBIT) | 0,6 | 0,6 | 0,8 | 33,5 |
Assets | 3,2 | 3,6 | 4,3 | 18,5 |
Net profit (loss) | 0,5 | 0,4 | 0,6 | 51,3 |
Cash | 2,5 | 3,2 | 3,6 | 13,9 |
Net income from sale | 8,8 | 9,7 | 9,8 | 0,2 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0,3 | 19,7 |
Working assets | 2,9 | 3,3 | 3,7 | 12,5 |
Other income costs | 0 | 0 | 0,2 | 891,3 |
Depreciation | 0 | 0,1 | 0,1 | 88,2 |
% | % | % | p.p. | |
Profitability of capital | 18,3 | 12,2 | 15,6 | 3,4 |
Equity capital to total assets | 93,2 | 92,8 | 92,8 | 0 |
Gross profit margin | 7,1 | 6,3 | 8,9 | 2,6 |
EBITDA Margin | 7,5 | 6,9 | 9,5 | 2,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 9 | 10 | 12 | 2 |
Current financial liquidity indicator | 13.51147747039795 | 12.802404403686523 | 12.029541015625 | -0,8 |
Net dept to EBITDA | -3.8046023845672607 | -4.70645809173584 | -3.8887054920196533 | 0,8 |
Financial statements
01-01-2024 - 31-12-2024
Annual financial report
Download xml01-01-2024 - 31-12-2024
Annual financial report
Download docx01-01-2024 - 31-12-2024
Activity report
Download pdf01-01-2024 - 31-12-2024
Resolution on profit distribution or loss coverage
Download pdf01-01-2024 - 31-12-2024
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
2M ACADEMY
Katowice
Pro Silesia sp. z o.o.
Opole